Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Seminars in Thrombosis and Hemostasis|March 27, 1998
Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failureB Eisele, M LamyJournal of Lipid Research|January 1, 1996
Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cellsM Mark, P Muller, R Maier, et al.Journal of Lipid Research|March 1, 1997
Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivoB Eisele, R Budzinski, P Müller, et al.Biomacromolecules|July 12, 2012
Viscoelasticity of thin biomolecular films: a case study on nucleoporin phenylalanine-glycine repeats grafted to a histidine-tag capturing QCM-D sensorNico B Eisele, Fredrik I Andersson, Steffen Frey, et al.EMBO Reports|April 10, 2010
Ultrathin nucleoporin phenylalanine-glycine repeat films and their interaction with nuclear transport receptorsNico B Eisele, Steffen Frey, Jacob Piehler, et al.Biophysical Journal|October 22, 2013
Cohesiveness tunes assembly and morphology of FG nucleoporin domain meshworks - Implications for nuclear pore permeabilityNico B Eisele, Aksana A Labokha, Steffen Frey, et al.Pharmacological Reviews|March 4, 2000
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedemaC Caliezi, W A Wuillemin, S Zeerleder, et al.Metabolism: Clinical and Experimental|December 3, 1999
Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular diseaseK Rühling, A Lang, F Richard, et al.Progress in Clinical and Biological Research|January 1, 1994
Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapyC E Hack, A C Ogilvie, B Eisele, et al.Intensive Care Medicine|January 1, 1993
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2C E Hack, A C Ogilvie, B Eisele, et al.Pageof 2